Finnect AI Insights

AI Business · · 4 min read

Can Treat's AI Really Fix Private Healthcare's Fragmented Incentives?

This article will explain how a new AI HealthTech startup, Treat, aims to disrupt the economic model of private healthcare by aligning incentives with efficient patient resolution, and what this means for businesses.

AI Business

Imagine going to a doctor nine times for the same issue, each visit adding to your stress, time, and bills, only to find all the necessary information was there from the start. This was the frustrating reality for Sami Marttinen's wife in private care, according to Marttinen.

It's a common story in healthcare: fragmented systems and a lack of incentive to 'connect the dots' efficiently. For many, the system rewards volume over value.

Now, Marttinen, co-founder of the successful Finnish recommerce company Swappie, is tackling this problem head-on. His new Helsinki-based HealthTech startup, Treat, just raised €3 million in pre-Seed funding, with the news reported on November 16-18, 2026.

The funding itself, led by byFounders with participation from Supercell founder Ilkka Paananen's investment vehicle Illusian, is a clear vote of confidence. byFounders was also an early backer of Lovable, according to sources.

But that's not the interesting part. The real story here isn't just another AI tool in healthcare; it's about a fundamental challenge to the economic model of private care. Treat's founders believe the current system rewards repeat visits over efficient resolution.

That raises three questions.

Question 1

What Exactly is the Core Problem Treat's AI Aims to Solve in Private Healthcare?

Sami Marttinen saw firsthand how a system designed to help can become a maze of inefficiency. His wife's nine repeat doctor visits in private care, all for a diagnosis that should have been clearer, highlighted a systemic flaw, he stated.

"The problem isn't the doctors," Marttinen explained, "It's an economic model that rewards repeat visits over efficient resolution." In conventional private care, revenue often comes from lab tests, clinic visits, and referrals, creating what he calls "billable runarounds." Why do these 'billable runarounds' persist in a system meant to heal?

Treat's solution, backed by a €3 million pre-Seed round from investors like byFounders and Illusian, explicitly avoids this model. "Our only incentive is solving the patient's issue on the spot," Marttinen stated. The startup, founded in 2026 by Marttinen, medical doctor Antti Mauno, and FinTech expert Onni Wahlberg, is built to challenge these misaligned incentives from the ground up.

And that brings us to the second question.

Question 2

How Does Treat's AI Platform Function to Streamline Care Without Diagnosing Patients?

You might wonder how AI can solve medical issues without actually making a diagnosis. Well, Treat's approach is clever. When a patient uses the platform, they describe their symptoms through a chat interface.

An AI-powered intake tool then steps in. This tool structures all that patient information into a detailed, coherent brief. Think of it like a highly efficient personal assistant at a government office (an illustrative example). Instead of you trying to explain your complex issue repeatedly to different clerks, this assistant gathers all your details, organises them perfectly, and presents a concise summary to the right official. Does this mean doctors are just reading an AI summary, or is there more to it?

Crucially, Treat's AI does not diagnose, assess urgency, or make automated decisions. Instead, a licensed physician, registered with the Finnish Supervisory Agency (Lupa- ja valvontavirasto), reviews this AI-prepared case and makes all the clinical decisions. As medical co-founder Antti Mauno commented, this removes delays and equips doctors with the best possible setup to help patients quickly get to "the right next step." All patient data remains within the European Economic Area (EEA) and is never used to train AI models.

And that brings us to the third question.

Question 3

What Could Treat's Approach Mean for Businesses and the Future of Workplace Health Benefits?

Treat is available directly to consumers for €72 per consultation, but its primary focus is on employers. The company offers its platform as a workplace health benefit, complementing existing occupational healthcare and private insurance.

For context, imagine your employees spending hours, or even days, on multiple doctor visits for an issue that could be resolved faster. Each visit means lost productivity, not to mention the direct healthcare costs. Treat aims to cut down on these "billable runarounds" by equipping doctors to solve issues efficiently, potentially reducing the overall number of consultations, lab tests, and referrals. But how does this translate into concrete benefits for your balance sheet and your team's well-being?

This could translate into significant savings and improved employee well-being for businesses. If employees get quicker, more effective care, they spend less time navigating fragmented systems and more time being productive. Sara Rywe, General Partner at byFounders, highlighted this, stating that Treat "fixes this at the root" by aligning technology with clinical workflows, setting a "new benchmark for primary care." Treat expects to be active in over five countries by the end of 2026, indicating rapid commercial expansion.

The Bigger Picture

Treat's model highlights a critical shift in how AI can be applied beyond pure automation. It's not just about replacing human tasks but about intelligently augmenting human professionals and fixing broken incentive structures.

This is a lesson for any business leader: sometimes the most impactful innovation isn't a new product, but a redesigned process that aligns economic incentives with the desired outcome.

Sami Marttinen's wife's nine doctor visits were a symptom of a larger problem. Treat is betting that smart AI, combined with a sharp focus on value, can turn that symptom into a solvable challenge, offering a glimpse into a future where efficiency and patient care are finally on the same side. The question is, how quickly will the rest of the industry catch on?

Quick Answers

What problem does Treat's AI aim to solve in private healthcare?

Treat's AI aims to fix the fragmented incentives in private healthcare that often reward repeat doctor visits and extensive procedures over efficient patient resolution. It seeks to reduce unnecessary appointments and streamline the care process.

How does Treat's AI platform work without diagnosing patients?

Treat's AI functions as an intelligent intake tool. Patients describe their symptoms via chat, and the AI structures this information into a detailed brief for a licensed physician. The AI does not diagnose, assess urgency, or make automated clinical decisions; these remain with human doctors.

What does Treat's approach mean for businesses?

For businesses, Treat offers its platform as a workplace health benefit, complementing existing occupational healthcare. By aiming for quicker, more efficient resolution of health issues, it could reduce overall healthcare costs, minimise lost employee productivity, and improve employee well-being.

Sources

Facts are credited to the outlets above. The analysis, calculations and Signal Check are by the Finnect AI Insights desk.